Breast Carcinoma In-Situ: Mammographic Risk Factors
Breast Carcinoma In-Situ: Mammographic Risk Factors
批准号:
7251931
负责人:
Elizabeth B. Claus
金额:
$29.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-01 至 2012-05-31
关键词:
AgeBasement membraneBlood specimenBreastBreast CarcinomaCancer PatientCarcinoma in SituCase-Control StudiesCharacteristicsClinicalCollectionComedoConnecticutDataData CollectionData SetDevelopmentDiagnosisDigit structureDisease MarkerDuctalDuctal EpitheliumEpitheliumExogenous Hormone TherapyFamily Cancer HistoryFamily history ofFemale Breast CarcinomaFollow-Up StudiesFundingGeneticGoalsGrantHealthcareHistologyHormone ReceptorIn SituIn Situ LesionIndividualInterviewInvasiveLesionLesion by StageLife StyleLiteratureLobuleLocationMalignant NeoplasmsMammary NeoplasmsMammographyMedicalMenopausal StatusMethodsModelingMutationNecrosisNoninfiltrating Intraductal CarcinomaNumbersOutcomeOutcome StudyParaffin EmbeddingParticipantPathologyPatternPopulationPopulation StudyPositioning AttributePregnancyPremalignantQuestionnairesRateRecording of previous eventsRiskRisk FactorsRoleSamplingScreening for cancerScreening procedureSeriesServicesStudy SubjectTP53 geneTelephone InterviewsTestingTimeUnited StatesWeightWomanagedbasebreast densitybreast lesioncalcificationcancer riskcase controlcohortcostdensityerbB-2 Receptorfollow-uplobular breast carcinoma in situmalignant breast neoplasmtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): As efforts to screen women using mammography have increased, so has the number of women diagnosed with breast carcinoma in-situ (BCIS). Clarification of the role of mammographic characteristics, such as mammographic breast density (MBD), with BCIS risk is important as 1) Up to 20% of screened breast cancer patients are diagnosed with this lesion and 2) increased MBD is associated with a 2-6 fold increase in the risk of invasive breast cancer. This project will study this association for the first time by collecting and reviewing mammograms in the largest population-based, case/control study of BCIS to date. The sample includes all cases of female BCIS aged 20 to 79 years diagnosed among residents of Connecticut from 9/15/94-3/14/98 as well as a series of age-matched random-digit-dial controls; these women (875 ductal carcinoma in-situ cases, 123 Iobular in-situ cases and 999 controls) are followed as part of our BCIS outcomes study. Information already collected includes 1) questionnaire data on family history of cancer, pregnancy menstrual history, exogenous hormone use, as well as cancer screening history, 2) follow-up interview data on lifestyle and medical outcomes, and, for cases, 3) paraffin embedded tumor blocks for immunohistochemical testing of ER, PR, p53 and HER-2/neu receptors, as well as 4) blood-samples for testing of mutations in BRCA1/BRCA2. We will examine whether 1) increased MBD or change in MBD is associated with BCIS risk, and 2) whether any correlation exists between clinical variables, mammographic characteristics, and outcome. This information will be used to 3) refine our models of breast cancer risk and to 4) examine whether mammograms can be characterized with respect to high and low risk outcomes. The addition of mammograms to a pre-existing epidemiologic cohort notable for its unique subject compositition, high participation rates, centralized pathology review and multi-disciplinary data collection, is a cost-efficient and scientifically valuable opportunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10294463
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2021
-
负责人:Elizabeth B. Claus
-
依托单位:
Participant Engagement Unit
-
批准号:10294464
-
项目类别:
-
资助金额:$299.93万
-
财政年份:2021
-
负责人:Elizabeth B. Claus
-
依托单位:
Genome Characterization Unit
-
批准号:10923429
-
项目类别:
-
资助金额:$47.28万
-
财政年份:2021
-
负责人:Elizabeth B. Claus
-
依托单位:
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)
-
批准号:10294462
-
项目类别:
-
资助金额:$312.3万
-
财政年份:2021
-
负责人:Elizabeth B. Claus
-
依托单位:
Participant Engagement Unit
-
批准号:10491842
-
项目类别:
-
资助金额:$326.93万
-
财政年份:2021
-
负责人:Elizabeth B. Claus
-
依托单位:
Administrative Core
-
批准号:10491839
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2021
-
负责人:Elizabeth B. Claus
-
依托单位:
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)
-
批准号:10491794
-
项目类别:
-
资助金额:$358.79万
-
财政年份:2021
-
负责人:Elizabeth B. Claus
-
依托单位:
The Meningioma Consortium: Genome-Wide Association Study
-
批准号:8547782
-
项目类别:
-
资助金额:$59.8万
-
财政年份:2010
-
负责人:Elizabeth B. Claus
-
依托单位:
The Meningioma Consortium: Genome-Wide Association Study
-
批准号:8332667
-
项目类别:
-
资助金额:$25.93万
-
财政年份:2010
-
负责人:Elizabeth B. Claus
-
依托单位:
The Meningioma Consortium: Genome-Wide Association Study
-
批准号:8089585
-
项目类别:
-
资助金额:$53.27万
-
财政年份:2010
-
负责人:Elizabeth B. Claus
-
依托单位:
Meningioma: Risk Factors and Quality of Life
-
批准号:7228421
-
项目类别:
-
资助金额:$68.85万
-
财政年份:2006
-
负责人:Elizabeth B. Claus
-
依托单位:
Meningioma: Risk Factors and Quality of Life
-
批准号:7789647
-
项目类别:
-
资助金额:$63.17万
-
财政年份:2006
-
负责人:Elizabeth B. Claus
-
依托单位:
Meningioma: Risk Factors and Quality of Life
-
批准号:7616505
-
项目类别:
-
资助金额:$70.78万
-
财政年份:2006
-
负责人:Elizabeth B. Claus
-
依托单位:
Meningioma: Risk Factors and Quality of Life
-
批准号:7049879
-
项目类别:
-
资助金额:$53.57万
-
财政年份:2006
-
负责人:Elizabeth B. Claus
-
依托单位:
Meningioma: Risk Factors and Quality of Life
-
批准号:7457694
-
项目类别:
-
资助金额:$69.09万
-
财政年份:2006
-
负责人:Elizabeth B. Claus
-
依托单位:
Meningioma: Risk Factors and Quality of Life
-
批准号:7798151
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2006
-
负责人:Elizabeth B. Claus
-
依托单位:
Breast Carcinoma In-Situ: Mammographic Risk Factors
-
批准号:7069541
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2004
-
负责人:Elizabeth B. Claus
-
依托单位:
Breast Carcinoma In-Situ: Mammographic Risk Factors
-
批准号:6780152
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2004
-
负责人:Elizabeth B. Claus
-
依托单位:
Breast Carcinoma In-Situ: Mammographic Risk Factors
-
批准号:6897898
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2004
-
负责人:Elizabeth B. Claus
-
依托单位:
LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU
-
批准号:6377148
-
项目类别:
-
资助金额:$57.66万
-
财政年份:2000
-
负责人:Elizabeth B. Claus
-
依托单位:
海外基金